标题 |
Patient-reported outcomes following ciltacabtagene autoleucel or standard of care in patients with lenalidomide-refractory multiple myeloma (CARTITUDE-4): results from a randomised, open-label, phase 3 trial
来那度胺难治性多发性骨髓瘤(CARTITUDE-4)患者接受ciltacabtagene autoleucel或标准治疗后患者报告的结局:一项随机、开放标签、3期试验的结果
|
网址 | |
DOI | |
其它 |
期刊:The Lancet Haematology 作者:Roberto Mina; Anne K Mylin; Hisayuki Yokoyama; Hila Magen; Winfried Alsdorf; et al 出版日期:2025 |
求助人 | |
下载 | 暂无链接,等待应助者上传 |